DexCom (DXCM) Tops Q4 EPS by 7c
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $69.75 +1.20%
EPS Growth %: +27.1%
Financial Fact:
Research and development: 43.9M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: +27.1%
Financial Fact:
Research and development: 43.9M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q4 EPS of $0.10, $0.07 better than the analyst estimate of $0.03. Revenue for the quarter came in at $221 million versus the consensus estimate of $215.87 million.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Starts DexCom (DXCM) at Buy
- ICON plc (ICLR) PT Raised to $150 at BofA Securities
- Dexcom Further Advances Vision of Glucose Biosensing for All
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
